L-T. Chen

1.2k citations

47 papers · 906 indexed · h-index 17

Impact in

Biotechnology top 5%
- Cancer Research and Treatments
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Oncology 16
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 5
Biotechnology 4
- Cancer Research and Treatments 4

Co-authors: Yu‐Wen Hsu (1 shared paper)Leonard Weiss (1 shared paper)L. Weiss (1 shared paper)Wu‐Chou Su (1 shared paper)Elizabeth Dito (1 shared paper)Margaret A. Tempero (1 shared paper)Andrew H. Ko (1 shared paper)A. Ong (1 shared paper)
Journals: Annals of Oncology (17 papers)Blood (4 papers)Blood Cancer Journal (3 papers)British Journal of Cancer (2 papers)Cell Death and Disease (1 paper)
Partner nations: Taiwan United States South Korea

In The Last Decade

L-T. Chen

44 papers receiving 891 citations

Peers

Countries citing papers authored by L-T. Chen

Since Specialization

Citations

This map shows the geographic impact of L-T. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L-T. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L-T. Chen more than expected).

Fields of papers citing papers by L-T. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L-T. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L-T. Chen. The network helps show where L-T. Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside L-T. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L-T. Chen Line = papers co-authored together L-T. Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients British Journal of Cancer ·TS Yang, SN Lu, Yee Chao, I.-Shyan Sheen, C-C. Lin, T. Wang, Shuo Chen, JH Wang, L-Y Liao, J. A. Thomson, Jacqueline Wang-Peng, Pei‐Jer Chen, L-T. Chen	2010	131
2	A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer British Journal of Cancer ·Andrew H. Ko, Margaret A. Tempero, Y-S Shan, Wu‐Chou Su, Yulin Lin, Elizabeth Dito, A. Ong, Y-W Wang, Chen‐Hao Yeh, L-T. Chen	2013	126
3	Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis Cell Death and Disease ·Barbara Delage, Phuong Luong, L Maharaj, Ciarán Ó’Riain, Nelofer Syed, Tim Crook, Eleftheria Hatzimichael, Alexandra Papoudou‐Bai, Tracey J. Mitchell, Sean Whittaker, Rebecca J. Cerio, John G. Gribben, Nicholas R. Lemoine, John S. Bomalaski, Chien‐Feng Li, S. Joel, Jude Fitzgibbon, L-T. Chen, Peter W. Szlosarek	2012	98
4	LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study Annals of Oncology ·Narikazu Boku, M.-H. Ryu, D-Y. Oh, Sang Cheul Oh, Hyun Cheol Chung, Kyung-Woo Lee, Takeshi Omori, Kohei Shitara, S. Sakuramoto, Ick‐Joong Chung, Kensei Yamaguchi, Katsuhiko Kato, Sun Jin Sym, Shigenori Kadowaki, Kunihiro Tsuji, Jin‐Shing Chen, L-Y. Bai, L-T. Chen, Y-K. Kang	2020	80
5	miR-520h is crucial for DAPK2 regulation and breast cancer progression Oncogene ·C-M Su, Minyu Wang, C-C Hong, H-A Chen, Y-H Su, C-H Wu, M-T Huang, Yi‐Wen Chang, S-S Jiang, S-Y Sung, J-Y Chang, L-T. Chen, Pisin Chen, J-L Su	2015	49
6	Development of Mouse Embryos in Vitro: Preimplantation to the Limb Bud Stage Science ·L-T. Chen, Yu‐Wen Hsu	1982	49
7	Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significance Blood Cancer Journal ·Sung‐Hsin Kuo, L-T. Chen, Chung‐Wu Lin, Ming‐Shiang Wu, Ping‐Ning Hsu, Hsin‐Ju Tsai, CY Chu, Y‐S Tzeng, H-P Wang, Kun‐Huei Yeh, Ann‐Lii Cheng	2013	42
8	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity Blood Cancer Journal ·Sung‐Hsin Kuo, Kun‐Huei Yeh, L-T. Chen, Chung‐Wu Lin, Hsu Pn, Chiun Hsu, Ming‐Shiang Wu, Tzeng Ys, Tsai Hj, H-P Wang, Ann‐Lii Cheng	2014	39
9	The development of vertebral bone marrow of human fetuses Blood ·L-T. Chen, Leonard Weiss	1975	32
10	The development of vertebral bone marrow of human fetuses Blood ·L-T. Chen, L. Weiss	1975	29
11	Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma Blood Cancer Journal ·Fang Liao, Yi‐Chiang Hsu, Sung‐Hsin Kuo, Yi‐Ching Yang, J-P Chen, Ping‐Ning Hsu, Chung‐Wu Lin, L-T. Chen, Ann‐Lii Cheng, Cathy S.J. Fann, J-T Lin, Ming‐Shiang Wu	2014	25
12	A Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02) Annals of Oncology ·Narikazu Boku, Y-K. Kang, Taroh Satoh, Yee Chao, Ken Kato, Hyun Cheol Chung, Jin‐Shing Chen, Kei Muro, Won Ki Kang, Takaki Yoshikawa, Sang Cheul Oh, Takao Tamura, Kyung-Woo Lee, L-T. Chen	2017	20
13	56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC) Annals of Oncology ·D-Y. Oh, A.R. He, S. Qin, L-T. Chen, T. Okusaka, A. Vogel, J.W. Kim, T. Suksombooncharoen, M.A. Lee, M. Kitano, H.A. Burris, M. Bouattour, S. Tanasanvimon, R.E. Zaucha, A. Avallone, J.E. Cundom, N. Rokutanda, M. Watras, G. Cohen, J.W. Valle	2022	19
14	Computed tomography, endoscopic ultrasonography and intraoperative assessment in TN staging of gastric carcinoma. PubMed ·Perng Ds, Jan Cm, Wang Wm, L-T. Chen, Su Yc, Liu Gc, Lin Hj, Huang Tj, Chao‐Yu Chen	1996	19
15	78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC) Annals of Oncology ·D-Y. Oh, A.R. He, S. Qin, L-T. Chen, T. Okusaka, A. Vogel, J.W. Kim, T. Lee, M.A. Lee, M. Kitano, H.A. Burris, M. Bouattour, S. Tanasanvimon, R.E. Zaucha, A. Avallone, J.E. Cundom, N. Rokutanda, M. Żotkiewicz, G. Cohen, J.W. Valle	2022	18
16	ATTRACTION-05 (ONO-4538-38/BMS CA209844): a randomized, multicenter, double-blind, placebo- controlled Phase 3 study of Nivolumab (Nivo) in combination with adjuvant chemotherapy in pStage III gastric and esophagogastric junction (G/EGJ) cancer Annals of Oncology ·Masanori Terashima, YW Kim, Yeh Ts, Hyun Cheol Chung, Jin‐Shing Chen, Narikazu Boku, Y-K. Kang, L-T. Chen, Mitsuru Sasako	2017	16
17	Intrasplenic microcirculation in rats with acute hemolytic anemia Blood ·L-T. Chen	1980	16
18	Intrasplenic microcirculation in rats with acute hemolytic anemia Blood ·L-T. Chen	1980	14
19	ATTRACTION-04 (ONO-4538-37): A randomized, multicenter, phase 2/3 study of nivolumab (Nivo) plus chemotherapy in patients (Pts) with previously untreated advanced or recurrent gastric (G) or gastroesophageal junction (GEJ) cancer Annals of Oncology ·L-T. Chen, Y-K. Kang, M Tanimoto, Narikazu Boku	2017	9
20	Hemopoiesis of the cultured whole mouse embryo. PubMed ·L-T. Chen, YC Hsu	1979	8

About L-T. Chen

L-T. Chen is a scholar working on Oncology, Biotechnology, Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 47 papers that have together received 906 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Research and Treatments (4 papers), Genetic factors in colorectal cancer (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). The work is most often cited by research in Biotechnology (165 citations), Cancer Research (203 citations), Oncology (299 citations), Gastroenterology (60 citations) and Pulmonary and Respiratory Medicine (238 citations). L-T. Chen has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Yu‐Wen Hsu, Leonard Weiss, L. Weiss, Wu‐Chou Su, Elizabeth Dito, Margaret A. Tempero, Andrew H. Ko, A. Ong, Chen‐Hao Yeh and Yulin Lin. Their work appears in journals such as Annals of Oncology, Blood, Blood Cancer Journal, British Journal of Cancer and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact